title: Evolution of HIV-1 in India.
abstract: Nearly 25 years after the discovery of the human immunodeficiency virus type 1 (HIV-1) effective control of the AIDS pandemic remains elusive. At the root of this challenge is the evolution of this virus to elude immune control. Error-prone nature of replication and retro-transcription is the hallmark of this virus. This fidelity of replication in HIV-1 is due to the absence of proof-reading/repair and post-replicative error correction mechanisms that normally operate during replication of DNA viruses. Advances in sequencing technology and expanded disease surveillance have allowed researchers to characterize the variation in HIV-1 around the world and within individual patient overtime. Although HIV-1 has been classified into distinct subtypes, the classification does not reflect dynamic genetic evolution of HIV-1 through which new strains are constantly emerging. The resultant viral diversity has implications for differential rates of disease progression in different geographical areas, differential responses to antiretroviral therapy (including the development of resistance), and vaccine development. In this review evolution of HIV-1 in India is discussed.
authors: Seth Research Foundation, H 8/3 First Floor, DLF Phase-I, Gurgaon, Haryana 122002 India.
authors: Pradeep
authors: P
authors: Seth
keywords: Evolution; HIV; HIV-1 diversity; HIV-1 subtype C; HIV-1 subtypes; Phylogenetic analysis
references: AIDS. 2000 Feb 18;14(3):289-96
references: 10716505
references: Clin Infect Dis. 2001 Jun 15;32(12):1732-7
references: 11360216
references: AIDS Res Hum Retroviruses. 2005 Feb;21(2):152-7
references: 15725754
references: J Virol. 2001 Nov;75(21):10479-87
references: 11581417
references: Cell. 2001 Feb 23;104(4):469-72
references: 11239404
references: AIDS Res Hum Retroviruses. 2004 Aug;20(8):889-94
references: 15320993
references: J Virol. 2000 Apr;74(8):3740-51
references: 10729149
references: J Med Virol. 2004 Oct;74(2):191-6
references: 15332265
references: AIDS Res Hum Retroviruses. 1999 Jul 1;15(10):941-4
references: 10408731
references: Lancet. 1998 Apr 25;351(9111):1250
references: 9643749
references: J Mol Evol. 2005 May;60(5):598-605
references: 15983869
references: J Acquir Immune Defic Syndr. 2004 Aug 15;36(5):1092-9
references: 15247563
references: AIDS Res Hum Retroviruses. 2007 Jul;23(7):934-40
references: 17678478
references: J Virol. 2002 Dec;76(24):12890-9
references: 12438614
references: J Virol. 1994 Apr;68(4):2161-8
references: 8139000
references: Science. 1998 Jun 19;280(5371):1868-71
references: 9669945
references: AIDS. 2005 Sep 2;19(13):1426-9
references: 16103776
references: AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1219-27
references: 12494921
references: Nat Med. 1998 Sep;4(9):1032-7
references: 9734396
references: AIDS. 1993 Jan;7(1):23-7
references: 8442916
references: J Virol. 1999 Jan;73(1):152-60
references: 9847317
references: AIDS Res Hum Retroviruses. 2005 Dec;21(12):1066-72
references: 16379612
references: J Virol. 1998 Jul;72(7):5680-98
references: 9621027
references: AIDS Res Hum Retroviruses. 1996 May 1;12(7):641-3
references: 8743090
references: J Virol. 2000 Nov;74(22):10498-507
references: 11044094
references: AIDS Res Hum Retroviruses. 2001 May 20;17(8):675-88
references: 11429108
references: AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1329-39
references: 8891112
references: J Virol. 1999 May;73(5):4393-403
references: 10196337